Foley Awarded 2013 M&A Advisor Deal of the Year in Healthcare/Life Sciences Category

20 December 2013 Media Contact: Jill Chanen News
Foley is pleased to announce that the firm’s work with OxOnc Development LP, was awarded “Deal of the Year in the Healthcare/Life Sciences (between $10 million to $50 million)” category at the 12th annual M&A Advisor awards gala on December 17, 2013. Foley attorneys, along with investment bankers MTS Health Partners, assisted in the formation and financing of OxOnc Development LP and its simultaneous entry into a significant development relationship with Pfizer, Inc. for the clinical development in the Peoples’ Republic of China, Japan, Taiwan and South Korea of Pfizer’s product, Xalkori, for the treatment of certain varieties of lung cancer. The Foley team consisted of Selig Sacks, Rick Kaufman, Jamshed Patel, Michael Dana and Melisande Brodeur-Frohman.

The M&A Advisor Awards recognize the leading dealmakers, firms and transactions.

Related Services

Insights

European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar